or Try an Advanced Search...

    Technical Analysis for RAPP - Rapport Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 23.26 1.44% 0.33
    RAPP closed up 1.44 percent on Friday, June 28, 2024, on 1.49 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A N/A N/A
    Historical RAPP trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Gapped Up Strength 0.00%
    Gapped Up Strength 1.44%
    Inside Day Range Contraction 0.00%
    Up 3 Days in a Row Strength 0.00%
    Gapped Down Weakness 0.00%
    Gapped Down Weakness 0.91%
    Older End-of-Day Signals for RAPP ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day 1 day ago
    Reversed from Up 1 day ago
    Up 5% 1 day ago
    1.5x Volume Pace 1 day ago
    Down 1% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    RAPP Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.
    Classification
    Keywords: Central Nervous System Disorders

    Is RAPP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 0 bearish and 5 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 12 Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
    Jun 7 Rapport Therapeutics starts trading above IPO price
    Jun 7 J&J-backed Rapport Therapeutics prices IPO at $17 per share
    Jun 6 Rapport Therapeutics Announces Pricing of Initial Public Offering
    Jun 3 J&J-backed Rapport Therapeutics sets terms for $136M IPO
    See more RAPP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 27.11
    52 Week Low 18.0
    Average Volume 121,481
    200-Day Moving Average 0.00
    50-Day Moving Average 0.00
    20-Day Moving Average 0.00
    10-Day Moving Average 0.00
    Average True Range 0.00
    RSI (14) 0.00
    ADX 0.0
    +DI 0.00
    -DI 0.00
    Chandelier Exit (Long, 3 ATRs) N/A
    Chandelier Exit (Short, 3 ATRs) N/A
    Upper Bollinger Bands 0.00
    Lower Bollinger Band 0.00
    Percent B (%b) 0.0
    BandWidth 0.00
    MACD Line 0.00
    MACD Signal Line 0.00
    MACD Histogram 0.0
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 25.56
    Resistance 3 (R3) 25.57 24.83 25.17
    Resistance 2 (R2) 24.83 24.24 24.82 25.04
    Resistance 1 (R1) 24.04 23.88 24.44 24.03 24.92
    Pivot Point 23.30 23.30 23.49 23.29 23.30
    Support 1 (S1) 22.51 22.71 22.91 22.50 21.60
    Support 2 (S2) 21.77 22.35 21.76 21.48
    Support 3 (S3) 20.98 21.77 21.35
    Support 4 (S4) 20.97